Preparation of and Formulation Comprising a Mek Inhibitor

Array Biopharma Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 7 of these applications claim priority to application 61/716,169, filed Oct 19, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Patent	Title	Holder	Status	Expires	Time remaining	Confidence
US 9,382,212	Preparation of and Formulation Comprising a Mek Inhibitor Array Biopharma, Inc. In force Term ends Oct 18, 2033 · High confidence	Array Biopharma, Inc.	In force	Term ends Oct 18, 2033	Term ends Oct 18, 2033	High confidence
US 9,562,016	Preparation of and Formulation Comprising a Mek Inhibitor Array Biopharma, Inc. In force Term ends Oct 18, 2033 · High confidence	Array Biopharma, Inc.	In force	Term ends Oct 18, 2033	Term ends Oct 18, 2033	High confidence
US 9,598,376	Preparation of and Formulation Comprising a Mek Inhibitor Array Biopharma, Inc. In force Term ends Oct 18, 2033 · High confidence	Array Biopharma, Inc.	In force	Term ends Oct 18, 2033	Term ends Oct 18, 2033	High confidence
US 9,980,944	Preparation of and Formulation Comprising a Mek Inhibitor Array Biopharma, Inc. In force Term ends Oct 18, 2033 · High confidence	Array Biopharma, Inc.	In force	Term ends Oct 18, 2033	Term ends Oct 18, 2033	High confidence
US 10,398,683	Preparation of and Formulation Comprising a Mek Inhibitor Array Biopharma Inc. In force Term ends Oct 18, 2033 · High confidence	Array Biopharma Inc.	In force	Term ends Oct 18, 2033	Term ends Oct 18, 2033	High confidence
US 10,729,678	Preparation of and Formulation Comprising a Mek Inhibitor Array Biopharma Inc. In force Term ends Oct 18, 2033 · High confidence	Array Biopharma Inc.	In force	Term ends Oct 18, 2033	Term ends Oct 18, 2033	High confidence
US 9,238,627	Preparation of and Formulation Comprising a Mek Inhibitor Array Biopharma, Inc. In force Term ends Apr 17, 2034 · High confidence	Array Biopharma, Inc.	In force	Term ends Apr 17, 2034	Term ends Apr 17, 2034	High confidence

7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.